Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Exp Parasitol ; 134(4): 413-21, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23707346

ABSTRACT

The most active metabolite of vitamin D, 1,25(OH)2D3 is a steroid hormone implicated in a wide range of cell functions such as differentiation, proliferation and apoptosis. Leishmania mexicana causes two kinds of cutaneous leishmaniasis: localized or diffuse. In this work we explored the effect of treatment of 1,25(OH)2D3 on a susceptible leishmaniasis mice model. A significant reduction in the lesion size was found in animals treated with 1,25(OH)2D3. Well preserved tissue and presence of large numbers of eosinophils and fibroblasts was found in the group treated with 1,25(OH)2D3. By contrast, destroyed epidermis was observed with large amount of neutrophils and epithelioid macrophages, on infected groups without 1,25(OH)2D3 treatment. The production of pro-inflammatory cytokines in mice infected and treated with 1,25(OH)2D3 was lower than the animals infected without 1,25(OH)2D3 treatment. Interestingly, there were no differences in the number of parasites in both groups. Finally, the amount of collagen was higher in animals with treatment compare with animals without 1,25(OH)2D3 treatment. In summary, mice treated with 1,25 (OH) 2D3 reflect a healing process without elimination of L. mexicana.


Subject(s)
Calcitriol/administration & dosage , Leishmania mexicana , Leishmaniasis, Cutaneous/drug therapy , Animals , Calcitriol/pharmacology , Calcitriol/therapeutic use , Collagen/metabolism , Cytokines/metabolism , Disease Models, Animal , Female , Immunohistochemistry , Injections, Intraperitoneal , Leishmania mexicana/drug effects , Leishmaniasis, Cutaneous/immunology , Leishmaniasis, Cutaneous/pathology , Mice , Mice, Inbred BALB C , Skin/parasitology , Skin/pathology
2.
Parasite Immunol ; 33(12): 643-53, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21851363

ABSTRACT

The innate immune system is the first line of defence against infection by pathogenic bacteria, virus and parasites and is also responsible for initiating an adaptive immune response. In contrast to the receptors of adaptive immunity (TCRs and antibodies) which are generated by gene recombination, receptors of the innate immune system are encoded in the germline and are thus inherited from generation to generation. Although evolutionarily selected, the genes encoding the innate recognition receptors show variations among individuals, and these polymorphisms may have an impact on the ability of an individual to deal with an infection. In recent years, several polymorphisms have been identified in innate recognition receptors, and efforts are being made to determine whether these polymorphisms are associated with a higher or lower susceptibility to infectious diseases. These studies will allow a better understanding of the role of innate receptors in specific diseases and are valuable in the design of preventive or therapeutic interventions to fight the disease. In this review, we summarize studies aimed at determining the influence of polymorphisms in innate recognition receptors on the susceptibility to diseases caused by parasites.


Subject(s)
Immunity, Innate , Parasitic Diseases/genetics , Polymorphism, Genetic , Receptors, Immunologic/genetics , Animals , Disease Resistance , Genetic Predisposition to Disease , Humans , Parasitic Diseases/immunology
3.
Parasite Immunol ; 30(8): 425-34, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18507782

ABSTRACT

The regulatory effect of mast cells on the pathogenesis of leishmaniasis is unclear. We report a comparative analysis of TLR2 membrane expression, TNF-α, IL-10 and MIP-1α production, and granule release of bone marrow-derived mast cells (BMMCs) from susceptible BALB/c and resistant C57BL/6 mice, stimulated in vitro with Leishmania mexicana lipophosphoglycan (LPG). We studied the kinetics of mast cell degranulation and parasite numbers in lesions of both mouse strains infected with L. mexicana. We found that BMMCs of C57BL/6 mice expressed more TLR2 and produced higher levels of both cytokines and MIP-1α, whereas BALB/c BMMCs significantly augmented their granule release. Lesions of BALB/c mice showed higher levels of degranulated mast cells at 3 h of infection, whereas after 3 days of infection, the number of degranulated mast cells in C57BL/6 was higher than in BALB/c lesions. Throughout infection, BALB/c mice harboured more parasites. The regulatory effect of mast cells seems to depend on the genetic background of the host: mast cells of BALB/c mice facilitate disease progression due to an augmented inflammatory response early in the infection, whereas mast cells of C57BL/6 mice produce cytokines that regulate inflammation and maintain an elevated number of immune cells in the lesions, promoting disease control.


Subject(s)
Glycosphingolipids/immunology , Leishmania mexicana/immunology , Leishmania mexicana/pathogenicity , Leishmaniasis, Cutaneous/genetics , Leishmaniasis, Cutaneous/immunology , Mast Cells/immunology , Animals , Cell Count , Cell Degranulation , Chemokine CCL3/biosynthesis , Disease Models, Animal , Interleukin-10/biosynthesis , Leishmaniasis, Cutaneous/pathology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Rodent Diseases/genetics , Rodent Diseases/immunology , Rodent Diseases/pathology , Skin/parasitology , Skin/pathology , Toll-Like Receptor 2/biosynthesis , Tumor Necrosis Factor-alpha/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL